And some perspective on the interesting PBM language floating around the Senate
And a new ICER effort falls short (even ICER thinks so)
And the CMS effort to gather patient input just looks worse and worse
And the quote of the week, from Zeke Emanuel: "The system sucks worse than ever."
And I have some issues with a new WaPo op-ed
And AbbVie puts a number on the IRA impact
And earnings calls have been notably quiet on policy discussions
And I'm bummed that JPM won't credential Cost Curve as media for the confab in January
And some thinking on the latest Sanders tempest
Plus new data that suggests that payers think Part D plans will get more expensive and less generous under the IRA
And PhRMA's research chiefs have some advice for Biden about moonshots
And more data that suggests that hospitals are not spending their 340B windfalls on charity care
